MELISSA WHITAKER: Open Payments
NPI 1790940146 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 36 payments from 11 companies in 2025. Trend: 2023 $905 · 2024 $842 · 2025 $776
Food & beverage: $681Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $220 |
| ABBVIE INC. | 9 | $168 |
| PFIZER INC. | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
| UCB, Inc. | 3 | $70 |
| Alexion Pharmaceuticals, Inc. | 2 | $37 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| KYOWA KIRIN, INC. | 1 | $21 |
| Amgen Inc. | 1 | $18 |
Products named: TREMFYA, XELJANZ, RINVOQ, ORENCIA, SKYRIZI, Bimzelx, STRENSIQ, ACTHAR.
Industry payments across KY — which companies pay providers there.
